These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6228736)

  • 41. The dynamics of innovation in minimally invasive therapy.
    Gelijns AC; Fendrick AM
    Health Policy; 1993 Jan; 23(1-2):153-66. PubMed ID: 10171340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endovascular surgery: issues and opportunities as we approach the new millennium.
    Beebe HG
    J Endovasc Surg; 1998 Feb; 5(1):1-5. PubMed ID: 9497199
    [No Abstract]   [Full Text] [Related]  

  • 43. What percentage of 1980 vascular surgery will be replaced by endovascular procedures in 2003?
    Diethrich EB
    J Cardiovasc Surg (Torino); 2003 Jun; 44(3):303-5. PubMed ID: 12832981
    [No Abstract]   [Full Text] [Related]  

  • 44. Minimally invasive surgery in the Federal Republic of Germany.
    Keuchel L; Beske F
    Health Policy; 1993 Jan; 23(1-2):49-65. PubMed ID: 10171344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examples of the influence of evaluation on health policy.
    Durieux P; Viens-Bitker C; Jolly D; Blum-Boisgard C
    Health Policy; 1988; 9(3):325-30. PubMed ID: 10302543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Charles Dotter: interventional radiologist.
    Friedman SG
    Radiology; 1989 Sep; 172(3 Pt 2):921-4. PubMed ID: 2528162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transluminal angioplasty.
    Dotter CT
    AJR Am J Roentgenol; 1980 Nov; 135(5):997-8. PubMed ID: 6778180
    [No Abstract]   [Full Text] [Related]  

  • 48. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease.
    Osterman FA
    N Engl J Med; 1992 Feb; 326(6):414; author reply 415-6. PubMed ID: 1530883
    [No Abstract]   [Full Text] [Related]  

  • 49. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease.
    Clugston RA; Eisenhauer AC; Matthews RV
    N Engl J Med; 1992 Feb; 326(6):415; author reply 415-6. PubMed ID: 1530884
    [No Abstract]   [Full Text] [Related]  

  • 50. Angioplasty in peripheral vascular disease.
    Reidy JF
    Postgrad Med J; 1987 Jun; 63(740):435-8. PubMed ID: 2963265
    [No Abstract]   [Full Text] [Related]  

  • 51. Transcatheter therapies in peripheral and noncoronary vascular disease. American Heart Association scientific conference. January 1989, Dallas, Texas. Proceedings.
    Circulation; 1991 Feb; 83(2 Suppl):I1-206. PubMed ID: 1671349
    [No Abstract]   [Full Text] [Related]  

  • 52. A surgeon's opinion of transluminal angioplasty.
    Strandness DE
    AJR Am J Roentgenol; 1980 Nov; 135(5):998-1000. PubMed ID: 6778181
    [No Abstract]   [Full Text] [Related]  

  • 53. Peripheral angioplasty--10 years on.
    Cumberland DC
    Clin Radiol; 1988 Nov; 39(6):573-4. PubMed ID: 2977312
    [No Abstract]   [Full Text] [Related]  

  • 54. Angioplasty and the cost of myocardial revascularization: has its promise been fulfilled?
    Reeder GS
    Int J Cardiol; 1987 Jun; 15(3):287-92. PubMed ID: 2954918
    [No Abstract]   [Full Text] [Related]  

  • 55. Introduction to the symposium on transluminal angioplasty.
    Bergan JJ
    Arch Surg; 1981 Jun; 116(6):804-5. PubMed ID: 7235977
    [No Abstract]   [Full Text] [Related]  

  • 56. Who doesn't need vascular medicine?--A team approach to vascular care and the role for vascular medicine.
    Banga JD
    Eur J Vasc Surg; 1993 Jan; 7(1):3-5. PubMed ID: 8454074
    [No Abstract]   [Full Text] [Related]  

  • 57. [The role of transluminal angioplasty in vascular surgery].
    du Toit DF; Laker L
    S Afr Med J; 1984 Aug; 66(5):162. PubMed ID: 6235603
    [No Abstract]   [Full Text] [Related]  

  • 58. Endovascular management of vascular disease: current technology and applications.
    Weaver FA; Hood DB
    Surg Clin North Am; 2004 Oct; 84(5):xi-xii. PubMed ID: 15364563
    [No Abstract]   [Full Text] [Related]  

  • 59. Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.
    Goldberg LD; Walt J
    Pharmacoeconomics; 2006; 24(3):251-64. PubMed ID: 16519547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment.
    Brevetti G; Annecchini R; Bucur R
    Pharmacoeconomics; 2002; 20(3):169-81. PubMed ID: 11929347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.